Pfizer Inc. (PFE)
NYSE: PFE · IEX Real-Time Price · USD
29.97
+0.26 (0.88%)
At close: Jul 19, 2024, 4:02 PM
30.12
+0.15 (0.50%)
Pre-market: Jul 22, 2024, 5:52 AM EDT
Pfizer Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for Pfizer stock have an average target of 35.69, with a low estimate of 27 and a high estimate of 50. The average target predicts an increase of 19.09% from the current stock price of 29.97.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Pfizer stock from 14 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Hold | 10 | 11 | 11 | 10 | 9 | 8 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 16 | 17 | 17 | 16 | 15 | 14 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Barclays | Barclays | Hold Maintains $28 → $30 | Hold | Maintains | $28 → $30 | +0.10% | Jul 10, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $45 | Buy | Reiterates | $45 | +50.15% | Jul 10, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $45 | Buy | Reiterates | $45 | +50.15% | Jul 1, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $45 | Buy | Reiterates | $45 | +50.15% | Jun 26, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $45 | Buy | Reiterates | $45 | +50.15% | Jun 20, 2024 |
Financial Forecast
Revenue This Year
61.19B
from 58.50B
Increased by 4.61%
Revenue Next Year
63.40B
from 61.19B
Increased by 3.61%
EPS This Year
2.37
from 0.37
Increased by 541.06%
EPS Next Year
2.76
from 2.37
Increased by 16.24%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 65.4B | 67.7B | 70.0B | 73.8B | 76.8B |
Avg | 61.2B | 63.4B | 63.9B | 65.0B | 62.9B |
Low | 57.0B | 57.6B | 57.9B | 57.9B | 53.8B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 11.7% | 10.7% | 10.3% | 15.5% | 18.1% |
Avg | 4.6% | 3.6% | 0.8% | 1.7% | -3.2% |
Low | -2.5% | -5.9% | -8.6% | -9.4% | -17.3% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 2.76 | 3.29 | 3.71 | 3.66 | 3.83 |
Avg | 2.37 | 2.76 | 2.93 | 3.07 | 2.88 |
Low | 2.11 | 2.33 | 2.47 | 2.54 | 2.11 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 646.4% | 38.6% | 34.4% | 25.2% | 25.0% |
Avg | 541.1% | 16.2% | 6.2% | 4.7% | -6.1% |
Low | 469.5% | -1.7% | -10.4% | -13.3% | -31.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.